Assembly Biosciences (ASMB) FCF Margin (2017 - 2026)
Assembly Biosciences (ASMB) posted quarterly FCF Margin of 269.28% for Q1 2026, down 2043.0% year-over-year from 13.86% in Q1 2025, and down 904.62% quarter-over-quarter from 33.47% in Q4 2025.
Powered by 
Analysis
Assembly Biosciences (ASMB) FCF Margin (2017 - 2026) Analysis & Trends
Assembly Biosciences' FCF Margin history runs 9 years deep, the most recent figure standing at 269.28% for Q1 2026.
- In Q1 2026, FCF Margin fell 2043.0% year-over-year to 269.28%; the TTM figure through Mar 2026 stood at 56.03% (up 11877.0% YoY), while the FY2025 annual figure was 56.93%, up 12240.0% from the prior year.
- FCF Margin for Q1 2026 stood at 269.28%, down from 33.47% in the prior quarter.
- The five-year high for FCF Margin was 1038.78% in Q4 2023, with the low at 317.68% in Q1 2024.
- The 4-year median for FCF Margin is 187.34% (2024), against an average of 50.71%.
- The sharpest annual moves came in 2024 and 2025: FCF Margin slumped 104431 bps in 2024, then jumped 8205 bps in 2025.
- Assembly Biosciences' FCF Margin stood at 1038.78% in 2023, then plunged by 101 bps to 5.53% in 2024, then soared by 705 bps to 33.47% in 2025, then sank by 905 bps to 269.28% in 2026.
- Business Quant data shows ASMB's FCF Margin at 269.28% in Q1 2026, 33.47% in Q4 2025, and 140.65% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Assembly Biosciences | 689.29 Mn | 368.93 Mn | - | -116.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -116.57% |
| Mar 31, 2026 | -269.28% |
| Dec 31, 2025 | 33.47% |
| Sep 30, 2025 | -140.65% |
| Jun 30, 2025 | -174.09% |
| Mar 31, 2025 | -248.85% |
| Dec 31, 2024 | -5.53% |
| Sep 30, 2024 | -222.70% |
| Jun 30, 2024 | -200.59% |
| Mar 31, 2024 | -317.68% |
| Dec 31, 2023 | 1,031.51% |
| Sep 30, 2021 | -181.23% |
| Dec 31, 2020 | -2,476.47% |
| Sep 30, 2020 | 24.57% |
| Jun 30, 2020 | -64.01% |
| Mar 31, 2020 | -619.53% |
| Dec 31, 2019 | -430.90% |
| Sep 30, 2019 | -438.97% |
| Jun 30, 2019 | -683.02% |
| Mar 31, 2019 | -572.77% |